Metoclopramide Cloridrato Noridem (Metoclopramide Hydrochloride Monohydrate)

The drug blocks dopamine D2 receptors in the brain’s chemoreceptor trigger zone and the gastrointestinal tract, reducing nausea signals. It also antagonizes peripheral 5‑HT3 receptors and stimulates gastric muscle activity, which together promote faster stomach emptying.

The specific dose and administration schedule are determined by the prescribing clinician based on the patient’s condition, age, weight, and renal or hepatic function. Healthcare professionals tailor the regimen to achieve optimal therapeutic effect while minimizing risk.

Safety data for Metoclopramide in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed), and import documentation.

Metoclopramide differs from many antiemetics by combining dopamine antagonism with pro‑kinetic activity, making it effective for both nausea control and gastric motility. Other agents, such as ondansetron, primarily block serotonin receptors without enhancing gastric emptying, so the choice depends on the clinical scenario.

The injectable solution should be stored at 2‑8 °C (refrigerated). Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking the container to maintain product stability.

Metoclopramide is given by intramuscular or intravenous injection, as directed by a healthcare professional. The route, rate of infusion, and duration are selected based on the indication and patient’s clinical status.

Serious adverse events include extrapyramidal symptoms such as dystonia, tardive dyskinesia with long‑term use, and neuroleptic malignant syndrome, a life‑threatening condition characterized by high fever and muscle rigidity. Prompt medical attention is required if these occur.

Patients with known hypersensitivity to metoclopramide or any component of the formulation should avoid the drug. Caution is also advised for individuals with a history of seizure disorders, severe depression, or uncontrolled movement disorders, and it is contraindicated in those with pheochromocytoma.